Clinical Trial Update: Prevention of Delayed CINV After Autologous Transplant: Olanzapine-Containing Regimen vs. Dexamethasone-Containing Regimen [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating whether an olanzapine-containing regimen can prevent delayed chemotherapy-induced nausea and vomiting after autologous stem cell tran…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• olanzapine (olanzapine)

Snippet

Sponsor: The Affiliated People's Hospital of Ningbo University | Conditions: Multiple Myeloma | Phase 3 | Status: RECRUITING